Finanzen von Ocugen Inc (OCGN)OCGNOcugen Inc

Evaluating the bottom line, Ocugen, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1105.11%, while the net margin is -1671.84%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively OCGN converts its operational activities into shareholder value.

In the context of the broader market, OCGN competes directly with industry leaders such as RZLT and RLMD. With a market capitalization of $457.80M, it holds a significant position in the sector. When comparing efficiency, OCGN's gross margin of 100.00% stands against RZLT's N/A and RLMD's N/A. Such benchmarking helps identify whether Ocugen, Inc. is trading at a premium or discount relative to its financial performance.

Ocugen's total revenue for Q2 2026 was $1,488,000, but it reported a net loss of $24,877,000, indicating significant financial strain. The gross margin remains strong at 100%, but the company is struggling with net income and profitability.